Literature DB >> 1889273

Antibiotic prophylaxis of respiratory tract infection in mechanically ventilated patients. A prospective, blinded, randomized trial of the effect of a novel regimen.

S J Aerdts1, R van Dalen, H A Clasener, J Festen, H J van Lier, E J Vollaard.   

Abstract

The objective of this study was to assess the effect of a novel regimen of antibiotic prophylaxis on the incidence of lower respiratory tract infection in patients requiring prolonged (at least five days) mechanical ventilation. The design was a controlled, prospective, randomized trial, with blinded comparison of the groups regarding the incidence of respiratory tract infection in an intensive care unit of a university hospital. After determination of the APACHE II score for severity of disease, 88 patients were randomly divided in three groups. Twenty-four of these patients did not complete five days of mechanical ventilation, and eight were withdrawn for other reasons. Fifty-six patients (18 in group 1, 21 in group 2, 17 in group 3) completed the study. Patients in both control groups 1 and 2 did not receive antibiotic prophylaxis, but the two groups differed in the antibiotic policy in case of infection. Patients in group 3 received antibiotic prophylaxis consisting of norfloxacin, polymyxin E, and amphotericin B, applied topically in oropharynx and stomach from time of ICU admission until extubation, and intravenous cefotaxime 500 mg three times a day during the first five days of admission. In both control groups, about 90 percent of the patients acquired microbial colonization of oropharynx or stomach. In group 3, only 12 percent and 24 percent of the patients acquired colonization of oropharynx and stomach, respectively (p less than 0.001). This resulted in a reduction of the incidence of lower respiratory tract infection (78 percent in group 1, 62 percent in group 2, 6 percent in group 3 [p = 0.0001]). The regimen of antibiotic prophylaxis studied prevented respiratory tract infection in mechanically ventilated patients. Antibiotic prophylaxis should be considered in all patients expected to require prolonged mechanical ventilation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1889273     DOI: 10.1378/chest.100.3.783

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  24 in total

1.  Effectiveness of antibiotic prophylaxis in critically ill adult patients: systematic review of randomised controlled trials.

Authors:  R D'Amico; S Pifferi; C Leonetti; V Torri; A Tinazzi; A Liberati
Journal:  BMJ       Date:  1998-04-25

Review 2.  The relationship between gut-derived bacteria and the development of the multiple organ dysfunction syndrome.

Authors:  G A Nieuwenhuijzen; E A Deitch; R J Goris
Journal:  J Anat       Date:  1996-12       Impact factor: 2.610

3.  Impact of selective digestive decontamination on respiratory tract Candida among patients with suspected ventilator-associated pneumonia. A meta-analysis.

Authors:  J C Hurley
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-04-26       Impact factor: 3.267

Review 4.  Selective decontamination of the digestive tract: indications and problems.

Authors:  H Lode; T Schaberg; R Stahlmann
Journal:  Infection       Date:  1995 May-Jun       Impact factor: 3.553

5.  Meta-analysis of randomised controlled trials of selective decontamination of the digestive tract. Selective Decontamination of the Digestive Tract Trialists' Collaborative Group.

Authors: 
Journal:  BMJ       Date:  1993-08-28

Review 6.  [Diagnosis and therapy of sepsis. Guidelines of the German Sepsis Society Inc. and the German Interdisciplinary Society for Intensive and Emergency Medicine].

Authors:  K Reinhart; F Brunkhorst; H Bone; H Gerlach; M Gründling; G Kreymann; P Kujath; G Marggraf; K Mayer; A Meier-Hellmann; C Peckelsen; C Putensen; M Quintel; M Ragaller; R Rossaint; F Stüber; N Weiler; T Welte; K Werdan
Journal:  Internist (Berl)       Date:  2006-04       Impact factor: 0.743

7.  Prevention of nosocomial infection in a pediatric intensive care unit (PICU) through the use of selective digestive decontamination.

Authors:  F Ruza; F Alvarado; R Herruzo; M A Delgado; S García; P Dorao; F Goded
Journal:  Eur J Epidemiol       Date:  1998-10       Impact factor: 8.082

8.  Efficacious topical treatment for murine cutaneous leishmaniasis with ethanolic formulations of amphotericin B.

Authors:  S Frankenburg; D Glick; S Klaus; Y Barenholz
Journal:  Antimicrob Agents Chemother       Date:  1998-12       Impact factor: 5.191

Review 9.  Selective decontamination of the digestive tract: the mechanism of action is control of gut overgrowth.

Authors:  Luciano Silvestri; Miguel A de la Cal; Hendrick K F van Saene
Journal:  Intensive Care Med       Date:  2012-09-22       Impact factor: 17.440

Review 10.  Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients.

Authors:  Andrea Cortegiani; Vincenzo Russotto; Alessandra Maggiore; Massimo Attanasio; Alessandro R Naro; Santi Maurizio Raineri; Antonino Giarratano
Journal:  Cochrane Database Syst Rev       Date:  2016-01-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.